Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Americhem is an active specialty polymer materials company that designs and manufactures custom color masterbatch, additive masterbatch, engineered thermoplastic compounds, and related performance materials for industrial and healthcare applications. In healthcare, the company supplies medical-grade polymer compounds and colorants used in devices such as auto-injectors, inhalers, nebulizers, surgical instruments, diabetes management systems, continuous glucose monitors, diagnostics consumables, and point-of-care equipment. Its business is commercial rather than therapeutic drug development, so it does not operate a conventional biotech pipeline; instead, it provides formulated material solutions, regulatory support, testing, and global manufacturing for OEMs. Americhem was founded in 1941, is headquartered in Cuyahoga Falls, Ohio, and operates manufacturing and sales sites across North America, Europe, and Asia. In 2025, Pritzker Private Capital agreed to acquire a majority stake in the company, with the business continuing to operate under the Americhem name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Americhem.